{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:38:39Z","timestamp":1785371919873,"version":"3.55.0"},"reference-count":83,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T00:00:00Z","timestamp":1254441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> This study aims to identify progression factors in patients with primary open\u2010angle glaucoma (POAG), including the effects of treatment with dorzolamide 2% or brinzolamide 1%, each added to timolol 0.5%.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A sample of 161 POAG patients were prospectively randomized to receive either dorzolamide 2% (DT) or brinzolamide 1% (BT) b.i.d., each added to timolol 0.5%, during a 60\u2010month, evaluator\u2010masked study. Progression was determined by perimetric criteria. Factors associated with visual field progression were estimated using a conditional Cox hazard model with patient intraclass correlation and were expressed as hazard ratios (HRs) with 95% confidence intervals (95% CIs).<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Predictive baseline factors were lower diastolic blood pressure (DBP), lower mean arterial pressure (MAP), antihypertensive treatment, lower end\u2010diastolic velocity (EDV) in the ophthalmic artery (OA) and short posterior ciliary artery (SPCA), and a higher resistivity index (RI) in the OA and SPCA. Progression risk decreased by approximately 30% and 20% with each centimetre per second increase of EDV in the OA and SPCA, respectively, from baseline to the last follow\u2010up visit. Each RI decrease (or increase) of 0.01\u2003unit in the OA or SPCA was associated with an approximate 20% decrease (or increase) in risk for progression. In a multivariate analysis, progression risk was significantly lower in eyes treated with DT (HR\u2003=\u20030.65, 95% CI 0.41\u20130.90) compared with those treated with BT.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Progression increased with lower DBP, lower MAP, antihypertensive medication, lower EDV in the OA and SPCA, and higher RI in the OA and SPCA. The risk for progression in patients treated with DT was half that in patients treated with BT.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2009.01595.x","type":"journal-article","created":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T10:57:33Z","timestamp":1254481053000},"page":"541-552","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open\u2010angle glaucoma"],"prefix":"10.1111","volume":"88","author":[{"given":"Antonio","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Sanchez\u2010Salorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,13]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-199812000-00007"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS) (7). The relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"Advanced Glaucoma Intervention Study Investigators","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01659-8"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1980.01020041015002"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080180084033"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050886"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.07.060"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2002.800211.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91046-6"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702886"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.8.1030"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01241-1"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.4.473"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00229-3"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","unstructured":"ChowS&RuskeyE(2004):Drawing area\u2010proportional Venn and Euler diagrams. In: Proc. of Graph Drawing 2003. Spring\u2010Verlag LNCS 2912.466\u2013477.","DOI":"10.1007\/978-3-540-24595-7_44"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91047-8"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.1.56"},{"key":"e_1_2_6_19_1","first-page":"55","volume-title":"Update to Glaucoma, Ocular Blood Flow, and Drug Treatment","author":"Drance SM","year":"1995"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00964-3"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.11.030"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.075"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.1.40"},{"key":"e_1_2_6_24_1","first-page":"954","article-title":"Cerebral blood flow and end\u2010tidal pCO2 during prolonged acetazolamide treatment in humans","volume":"258","author":"Friberg L","year":"1990","journal-title":"Am J Physiol"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1972.01000020072015"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.067637"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000048311"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.121.12.1711","article-title":"Ocular haemodynamics and glaucoma prognosis: a colour Doppler imaging study","volume":"121","author":"Galassi F","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.714"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(82)34675-8"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1997.tb00763.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.7.2716"},{"key":"e_1_2_6_33_1","first-page":"52","volume-title":"Clinical Decisions in Glaucoma","author":"Hodapp E","year":"1993"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1982.tb08381.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/108076804772745419"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01279.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2004.00358.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.11.010"},{"key":"e_1_2_6_39_1","first-page":"2461","article-title":"Appropriate statistical methods to account for similarities in binary outcomes between fellow eyes","volume":"35","author":"Katz J","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30192-4"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.9.1137"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.021485"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0048"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.8.1003"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.1.48"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.016"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080040095036"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(99)00343-8"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00567.x"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X80215"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01126.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.06.006"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702676"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0841-4"},{"key":"e_1_2_6_55_1","first-page":"1270","article-title":"Dorzolamide effect on the ocular blood flow","volume":"40","author":"Martinez A","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.047"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503021102"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-005-0273-1"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.02.017"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0204"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.9.1176"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210801800303"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00754.x"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004170050268"},{"key":"e_1_2_6_65_1","first-page":"4671","article-title":"Indications de l\u2019ultrasonographie Doppler dans l\u2019etude des vaisseaux peripheriques","volume":"25","author":"Pourcelot L","year":"1975","journal-title":"Rev Prat"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1117\/12.195229"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)02156-6"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.01108.x"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0125"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/42.9.8064130"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00107-1"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.125187"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00095-6"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701605"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560070303"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00487-6"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100080061030"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(99)00006-3"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1171"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.224.7.1039d"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.5.621"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.10.1345"},{"key":"e_1_2_6_83_1","first-page":"413","article-title":"Carbonic anhydrase inhibition in ophthalmology: carbonic anhydrases in cornea, lens, retina and lacrimal gland","volume":"90","author":"Wistrand PJ","year":"2000","journal-title":"EXS"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.093633"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2009.01595.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2009.01595.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:47:36Z","timestamp":1698731256000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2009.01595.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,13]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1755-3768.2009.01595.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01595.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,13]]},"assertion":[{"value":"2010-07-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}